Royal Bank Of Canada Compugen LTD Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.58 - $1.2 $9 - $20	17 Added 1700.0%	18 $0
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $20 - $43	-13 Reduced 92.86%	1 $0
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $315,942 - $531,150	-114,472 Reduced 99.99%	14 $0
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $35,390 - $61,955	-8,653 Reduced 7.03%	114,486 $493,000
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $562 - $777	-97 Reduced 0.08%	123,139 $735,000
Q2 2021 Aug 16, 2021	BUY	$6.87 - $9.16 $846,631 - $1.13 Million	123,236 New	123,236 $1.02 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.